Multiple Sclerosis
Relapses, progression, fatigue and walking: research on how MS behaves and how to slow it.
Every area page explains what studies there look at, what taking part usually involves and the lines their listings often use, then opens a live search of the public register.
Relapses, progression, fatigue and walking: research on how MS behaves and how to slow it.
For seizures that keep coming despite treatment: added medicines, devices, diet and detection.
A cough that stays for months after tests find no cause. Research on the reflex behind it.
Patchy, pattern and scarring hair loss: research on medicines, devices and why it happens.
Painful flares and the uric acid behind them: research on lowering it and calming attacks.
Low iron and low red cells: research on infusions, tablets and the conditions behind them.

Yes. Orva writes about all six areas, and its updates follow them. If they stop being useful, reply STOP to any text.
Orva only writes about these six areas, but ClinicalTrials.gov lists studies in every area of health, and our guide to reading a study listing works for any of them.
It is a good idea. Your doctor knows your history and can help you think through whether a study suits you. Taking part never replaces your regular care.
No. A text or email from Orva can tell you about research, but it never enrolls you in anything. If a study interests you, you contact its team yourself, and the team decides who takes part.
Occasional texts or emails about research in Orva’s six areas, from Orva alone.
Go to the sign-upIt is free, the text box is optional, and one reply stops the texts.